Combination Bevacizumab and PRGN-2012 in Adults With Recurrent Respiratory Papillomatosis (RRP)

Citation record

Study start

2026-10-28

NCT number

NCT07756840

Phase

Phase2

Overall status

Not Yet Recruiting

Study type

Interventional

Lead sponsor

National Cancer Institute (NCI)

Enrollment

50 participants

Conditions

Respiratory Recurrent Papillomatosis (RRP) · Human Papillomavirus (HPV) · Papillomavirus Infection · Laryngeal Diseases · Tracheal Diseases · Respiratory Tract Neoplasm

Interventions

PRGN-2012 (Drug) · Bevacizumab (Drug)

Last updated at source

23 Oct 2026

Original source

https://clinicaltrials.gov/study/NCT07756840

This page reproduces citation metadata only. Inclusion in the Avion Science research library does not imply endorsement and does not establish the safety, efficacy or intended use of any Avion Science compound. Refer to the original record for complete study information.